Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Pro Medicus Limited ( (AU:PME) ) has shared an update.
Pro Medicus Limited has provided an updated notification to the ASX regarding its on-market share buy-back of ordinary fully paid shares under code PME. The company reported that it had repurchased a total of 45,324 shares prior to the previous trading day and a further 3,200 shares on the previous day, as part of an ongoing buy-back program first notified in April 2025, with this update dated 19 December 2025, indicating continued capital management activity that may support earnings per share and signal confidence in the company’s valuation to investors.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$350.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Average Trading Volume: 174,307
Technical Sentiment Signal: Hold
Current Market Cap: A$23.62B
For detailed information about PME stock, go to TipRanks’ Stock Analysis page.